about-me variable
ISMIE Risk Management invites you to their event

Medication Safety Considerations During the COVID-19 Pandemic

About this event

In the midst of the COVID-19 pandemic, information relating to medications used for treatment is rapidly changing. This presents significant risk for physicians and their patients as adding to a patient’s medication regimen can lead to adverse drug interactions and polypharmacy. Minimizing the risks associated with potential additions of medications is of utmost importance in providing safe patient care.

Join us as clinical pharmacists Heather Rozea Cooper, PharmD, BCPP, and Quratulain (Anna) Zulfiqar, PharmD, review ways to stay up-to-date on the most current guidance for treatment of COVID-19, common adverse effects and the risk management strategies that exist for commonly used COVID-19 treatments and supportive/alternative therapies.

Who can attend

Registration is limited to ISMIE and SEMPIC policyholders, ISMS members, and their employed staff.

Learning objectives

  1. List resources available for updated guidance on medications used for COVID-19 treatment
  2. Identify differences between theorized and evidence-based treatment modalities for COVID-19
  3. Summarize adverse events and monitoring parameters for medications and supporting therapies for COVID-19

About the presenters

Dr. Heather Cooper is a Clinical Pharmacy Specialist at The University of Texas Health Science Center at Houston (UTHealth). Dr. Cooper completed two years of residency training in the Veterans Affairs healthcare system with a focus in psychiatry, and is board certified in psychiatric pharmacy.

Dr. Quratulain (Anna) Zulfiqar is a Clinical Pharmacist at The University of Texas Health Science Center at Houston (UTHealth). She completed her pharmacy school at the University of Houston College of Pharmacy and her post graduate residency training at the Department of Veterans Affairs (VA) focusing in ambulatory care.

Dr. Cooper and Dr. Zulfiqar are currently the two research pharmacists working on a geriatric deprescribing study, funded by Blue Cross Blue Shield, for which Dr. Holly Holmes is the primary investigator.

Disclosure

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.

CME information

ISMS logoThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Illinois State Medical Society and ISMIE Mutual Insurance Company. The Illinois State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

The Illinois State Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Illinois Nurse Practice Act rules deem CME credit provided by approved sponsors as acceptable to fulfill nursing continuing education requirements for licensure. Nurses may claim one contact hour per unit of CME in the state of Illinois.

ISMIE Risk Management

Our Passion Protects Yours

ISMIE Mutual provides superior insurance services to medical practices and providers, delivering quality, value and protection to policyholders everywhere.